Newsroom

A key focus at the Helmholtz Centre for Infection Research (HZI) and its sites like the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is translating research findings into medical and pharmaceutical applications. Beyond scientific collaboration, the goal is to facilitate the transfer of technology and knowledge into practical and potentially commercial uses. Recently, the company MyxoTech has been founded as a HIPS spin-off. MyxoTech CEO Peter Sullivan explains what the new company is about and what it wants to achieve.

The current outbreak of the Mpox virus originated in Central Africa. A first case has now been discovered in Europe. The WHO has declared the highest alert level. In an interview with Helmholtz, Fabian Leendertz, Director of the Helmholtz Institute for One Health (HIOH), puts the events in context.

Dr. Chantal Bader is the first candidate of the Young AcademiXX program at Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with Saarland University. After completing her PhD in the HIPS Department Microbial Natural Products, she spent just over two years as a postdoctoral researcher in Ben Shen's group at the Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Florida, USA. She has now returned to Saarbrücken and is laying the foundation for her future scientific career with her participation in the Young AcademiXX program. In this interview, she talks about her connection to HIPS, her plans for the future and how Young AcademiXX is helping her to put them into practice.

One would expect a high school graduate to have little time for extracurricular activities shortly before the final written exams. Nevertheless, Alexander Becker can regularly be found in the laboratories of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), even at this time of year. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. There, the 18-year-old student from the Gymnasium am Stefansberg in Merzig is trying to isolate myxobacteria from unusual soil samples. His work is part of a project with which he successfully took part in the Jugend forscht competition for young scientists. Together with ten other students from Saarland, he qualified for the 59th national Jugend forscht competition, which will take place in Heilbronn from May 30 to June 2, 2024.

The message is clear: The Helmholtz Centre for Infection Research (HZI) aims to become one of the world's premier infection research institutes. Professor Josef Penninger, Scientific Director of the HZI since 1 July 2023, has set the bar high. Christian Scherf, the Administrative Director of the HZI since 1 January 2023, is going to do everything in his power to support him.

Martin Korte researches the influence of infections and infection-associated inflammations on neurodegenerative diseases that damage, for example, learning processes or memory. Korte is group leader of the “Neuroinflammation and Neurodegeneration” research group at the Helmholtz Centre for Infection Research (HZI) and director of the Zoological Institute at the Technische Universität Braunschweig where he also holds a professorship for Cellular Neurobiology. A newly emerging field of research are the symptoms summarily known as "long COVID", which continue to manifest for months in about ten per cent of patients after overcoming a COVID-19 disease. In this interview, Martin Korte explains these long-term consequences, which are the subject of his new book (in German).